Hyperliquid Strategies posts $165.4M loss, including $64M on HYPE

Hyperliquid Strategies posted a $165.4 million net loss for the nine months ending March 31. The result included $64 million in unrealized losses on HYPE holdings, a $35.6 million one-time write-off tied to the Sonnet BioTherapeutics acquisition, and $60.5 million in deferred income taxes. The company said it held $103 million in cash and about 20 million HYPE tokens.

HYPE-0.28%
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin